α7-nAChR and EGFR are both enhance the cancer cell proliferation via activation of the PI3K/AKT/mTOR signaling pathway, and PTEN is a major negative regulator of this pathway (Misiura et al., 2020; Witayateeraporn et al., 2020; Cochard et al., 2021). Here, PTEN is linked to cancer.